1
Exhibit 10.36
Xxxxxxxxx Securities, Inc.
0 Xxxxxxx Xxxxxx
Xxxxxxxxxx, X.X.
Implant Sciences Corporation
Wakefield, MA
Ladies and Gentlemen:
In order to induce Xxxxxxxxx Securities, Inc. (the "Underwriter") and Implant
Sciences Corporation and any successor thereof (the "Company"), to enter into an
underwriting agreement with respect to the Unit offering to be issued by the
Company as described in the Company's Registration Statement on Form SB-2, the
undersigned officers and directors hereby agree that for a period of thirteen
(13) months following the closing of the offering, the undersigned will not
sell, transfer, assign, hypothecate, pledge or otherwise dispose of any
beneficial interest in (either pursuant to Rule 144 or the regulations under the
Securities Act of 1933, as amended, or otherwise) any securities issued by the
Company (the "Securities") registered in the name of the undersigned or
beneficially owned by them without the prior written consent of the Underwriter.
The Company also agrees that in connection with acquisitions, the Company will
not without the Underwriter's prior written consent, sell, or offer to sell,
either publicly or privately, any shares of common stock, other equity, debt or
convertible securities for thirteen (13) months after the closing. The Company
may issue shares of common stock or other securities upon the exercise of
currently outstanding options and warrants or options hereafter issued.
Implant Sciences Corporation
by__________________________
Dated:______________________
_______________________ ____________________________ _______________________
_______________________ ____________________________ _______________________
_______________________ ____________________________ _______________________
